Journal articleJ Immunother2012
Monoclonal antibody therapy of pancreatic cancer with cetuximab: potential for immune modulation.
- Journal
- J Immunother
- Published
- 1 June 2012
- Citations
- 24
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Pancreatic cancer is a devastating disease, with a median survival of around 6 months for patients with stage IV disease. The epidermal growth factor receptor (EGFR, or HER1) belongs to the erbB receptor tyrosine kinase family. … Excerpt only: this text is the publisher’s. Read it in full at the source.